Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Bioanalysis
|
February 19, 2013
Metabolite structure analysis by high-resolution MS: supporting drug-development studies
David S Wagner, Jill L Pirhalla, Gary D Bowers
Toxicologic Pathology
|
December 12, 2024
Mass Spectrometry Imaging Distinguishes Biliary Toxicants on the Basis of Cellular Distribution
Junhai Yang, Andrew P Bowman, Wayne R Buck, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 27, 2022
Evaluation of Quantitative Platforms for Single Target Mass Spectrometry Imaging
Andrew P Bowman, James Sawicki, Nari N Talaty, et al.
Journal of Mass Spectrometry : JMS
|
August 12, 2025
Spatial Mapping of Gangliosides and Proteins in Amyloid Beta Plaques at Cellular Resolution Using Mass Spectrometry Imaging and MALDI-IHC
Christopher J Good, Andrew P Bowman, Corinna Klein, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 21, 2024
Utility of Common In Vitro Systems for Predicting Circulating Metabolites
Elyse C Freiberger, Michael P Thompson, Xiaomei Zhang, et al.
Journal of Applied Toxicology : JAT
|
August 19, 2014
Cardiolipin profiles as a potential biomarker of mitochondrial health in diet-induced obese mice subjected to exercise, diet-restriction and ephedrine treatment
Catherine Faber, Zhaohai J Zhu, Stephen Castellino, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 2, 2012
Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studies
James F Sigafoos, Gary D Bowers, Stephen Castellino, et al.
Clinical Pharmacology and Therapeutics
|
December 11, 2023
Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group
Wenkui Li, Faye Vazvaei-Smith, Gordon Dear, et al.
Clinical Pharmacology and Therapeutics
|
November 29, 2023
Non-Labeled, Stable Labeled, or Radiolabelled Approaches for Provision of Intravenous Pharmacokinetics in Humans: A Discussion Piece
Graeme C Young, Douglas K Spracklin, Alexander D James, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 12, 2024
Recommendations on the Use of Multiple Labels in Human Mass Balance Studies
Filip Cuyckens, Mette G Hvenegaard, Kenneth C Cassidy, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Bioanalysis
|
February 19, 2013
Metabolite structure analysis by high-resolution MS: supporting drug-development studies
David S Wagner, Jill L Pirhalla, Gary D Bowers
Toxicologic Pathology
|
December 12, 2024
Mass Spectrometry Imaging Distinguishes Biliary Toxicants on the Basis of Cellular Distribution
Junhai Yang, Andrew P Bowman, Wayne R Buck, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 27, 2022
Evaluation of Quantitative Platforms for Single Target Mass Spectrometry Imaging
Andrew P Bowman, James Sawicki, Nari N Talaty, et al.
Journal of Mass Spectrometry : JMS
|
August 12, 2025
Spatial Mapping of Gangliosides and Proteins in Amyloid Beta Plaques at Cellular Resolution Using Mass Spectrometry Imaging and MALDI-IHC
Christopher J Good, Andrew P Bowman, Corinna Klein, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 21, 2024
Utility of Common In Vitro Systems for Predicting Circulating Metabolites
Elyse C Freiberger, Michael P Thompson, Xiaomei Zhang, et al.
Journal of Applied Toxicology : JAT
|
August 19, 2014
Cardiolipin profiles as a potential biomarker of mitochondrial health in diet-induced obese mice subjected to exercise, diet-restriction and ephedrine treatment
Catherine Faber, Zhaohai J Zhu, Stephen Castellino, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 2, 2012
Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studies
James F Sigafoos, Gary D Bowers, Stephen Castellino, et al.
Clinical Pharmacology and Therapeutics
|
December 11, 2023
Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group
Wenkui Li, Faye Vazvaei-Smith, Gordon Dear, et al.
Clinical Pharmacology and Therapeutics
|
November 29, 2023
Non-Labeled, Stable Labeled, or Radiolabelled Approaches for Provision of Intravenous Pharmacokinetics in Humans: A Discussion Piece
Graeme C Young, Douglas K Spracklin, Alexander D James, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 12, 2024
Recommendations on the Use of Multiple Labels in Human Mass Balance Studies
Filip Cuyckens, Mette G Hvenegaard, Kenneth C Cassidy, et al.
Page
of 2